Benet J. O'Reilly
Partner
Benet J. O’Reilly’s practice focuses on public and private mergers and acquisitions, private equity investments, and restructuring transactions.
He has significant experience across a broad array of industries, including TMT, pharmaceuticals and health care, and industrials. He also has experience in cross-border transactions and securities offerings.
Benet joined the firm in 1999 and became a partner in 2008.Notable Experience
Technology, Media, and Telecommunications Experience
-
Synopsys in its pending $35 billion acquisition of Ansys and the pending sale of its Optical Solutions Group to Keysight Technologies.
-
Atlassian in its $975 million acquisition of Loom.
-
American Tower in its sale of an approximately 29% ownership interest and $570 million follow-on sale of additional interests in its U.S. data center business to Stonepeak, its $10.1 billion acquisition of CoreSite, and its $3.5 billion acquisition of InSite.
-
Schibsted, the majority shareholder of Adevinta, in Adevinta’s $9.2 billion acquisition of eBay Classifieds.
-
Defenders in its $381 million sale to ADT.
-
Google in its acquisition of Jibe Mobile.
-
Agilent Technologies in its $2.2 billion acquisition of Dako A/S from EQT.
-
Brightstar and its founder in SoftBank’s $1.26 billion acquisition of a 57% interest in Brightstar.
-
Stanley Black & Decker in its acquisition of AeroScout.
-
SMSC in its sale to Microchip Technologies and prior acquisition of BridgeCo.
-
Newcastle Investment Corp. in its acquisition of certain print and digital publishing assets from Halifax Media Group and Local Media Group from News Corp., as part of the prepackaged Chapter 11 restructuring of GateHouse Media Inc.
-
CVCI in its acquisition of Ness Technologies and investment in and recapitalization of SourceHOV.
-
Hewlett-Packard in its acquisitions of 3PAR, 3Com, EDS, Opsware, Neoware, Knightsbridge Solutions, and Peregrine Systems.
-
VeriSign in the sale of its authentication business to Symantec.
-
TPG Capital and Goldman Sachs Capital Partners in their acquisition of Alltel Corporation and subsequent sale of Alltel to Verizon Wireless.
-
PeopleSoft in responding to Oracle’s unsolicited tender offer and in the negotiation of PeopleSoft’s acquisition at a price 65% above Oracle’s initial bid.
Pharmaceuticals and Health Care Experience
-
Surescripts in its strategic partnership with TPG Capital.
-
Asahi Kasei in its $1.1 billion acquisition of Calliditas Therapeutics.
-
GSK in its acquisitions of Aiolos, Sierra Oncology, Human Genome Sciences, Stiefel Laboratories, Reliant Pharmaceuticals, and Genelabs, and its investments in Theravance.
-
CareCentrix in its sale to Walgreens Boots Alliance.
-
MEDNAX in its sales of American Anesthesiology to North American Partners in Anesthesia and MedData to Frazier Healthcare Partners.
-
Kindred Healthcare in its $4.1 billion sale to a consortium led by TPG Capital, Welsh Carson Anderson & Stowe, and Humana, and previously in Kindred’s acquisitions of Gentiva and RehabCare, and its sale of 24 non-strategic nursing centers.
-
Viking Global Investors in its equity investments in Adaptive Biotech and Moderna.
-
RxHub in its merger with SureScripts.
Consumer Experience
-
Post Holdings in its distribution of its interest in BellRing Brands.
-
JUUL in a $12.8 billion investment by Altria.
-
ESL Investments with respect to its investment in Sears, including its $5.2 billion acquisition of Sears.
-
Viking Global Investors in its acquisition of Birchbox and equity investments in Credit Karma.
-
Suntory in its $16 billion acquisition of Beam.
-
The Coca-Cola Company in the restructuring of its joint venture with Nestlé in the tea beverage business and its acquisition of bottling operations in Vietnam and Cambodia from Coca-Cola Sabco.
-
Genting Hong Kong in its acquisitions of Crystal Cruises from NYK and Norwegian Cruise Line’s $3 billion acquisition of Prestige Cruises.
-
The Home Depot in various acquisitions, including of Hughes Supply and White Cap Construction Supply.
-
Transform Holdco and ESL Investments in Transform Holdco’s acquisition of Sears Hometown and Outlet Stores.
Chemicals and Industrial Experience
-
IFF in its $1.3 billion sale of its Microbial Control business unit to Lanxess, $45.4 billion Reverse Morris Trust merger with DuPont’s Nutrition & Biosciences business, and acquisitions of Frutarom, PowderPure, and David Michael.
-
Vale in its $2.5 billion sale of its fertilizer business to The Mosaic Company.
-
Asahi Kasei in its $2.2 billion acquisition of the energy storage business of Polypore.
-
Altana in its acquisition of the rheology additives business of Rockwood Holdings Inc.
-
Lafarge in the sale of cement plants and related assets to Eagle Materials and Cementos Argos.
-
ACON Investments and TPG Capital in their acquisition of a refinery and related downstream assets from Marathon Oil to form Northern Tier Energy.
Financial Services Experience
-
Viking Global Investors in its equity investments in Credit Suisse.
-
Barclays PLC in the sale of its NYSE-designated market maker business to GTS Securities.
-
OneWest Bank in its $3.4 billion sale to CIT Group.
-
Bank of America in its $1 billion sale of the long-term asset management business of Columbia Management to Ameriprise Financial.
-
thinkorswim Group in its cash/stock merger with TD Ameritrade.
Private Equity and Other Select Experience
-
Generation Asset Management in its investment in bike-share operator Motivate.
-
TRAC Intermodal (a portfolio company of Fortress Investment Group) in the sale of its domestic chassis fleet to Direct ChassisLink Inc.
-
TPG Capital in its investment in Creative Artists Agency.
-
Booz & Company in its combination with PwC.
Publications
Cleary’s Pharma Bites: Contingent Value Rights (CVRs) in Pharmaceutical Deals
AI May Do Wonders for Your Business, But What About Your Risk Profile?
FTC Proposes Rule to Ban Non-Competes
Is Biopharma Poised For Bigger Deals in 2022?
Between Contractual and Fiduciary Duties: ODN Holding and the Rights of Preferred Stockholders
Is Tracking Stock, Often Considered a Bygone Darling of the 90’s Tech Boom, in Line for a Comeback?
Antitrust, IP, Board Processes, and M&A in 2016: Key Takeaways
Delaware Chancery Court Reaffirms Limitations on Preferred Stock Redemptions
A Degree of Certainty Restored to Assignment by Operation of Law: Meso Scale v. Roche Redux
A New Wrinkle in the Interpretation of Anti-Assignment Clauses
Events
-
July 11, 2024
Artificial Intelligence in the Boardroom: What Board and Senior Executives Need to Know
-
March 15, 2023
Transaction Advisors’ M&A Conference at Wharton San Francisco 2023
-
June 23, 2020
Representation & Warranties Insurance: How Has It Changed Private M&A and What Lies Ahead?
-
May 8, 2018
-
January 29, 2016
Antitrust, IP, Board Processes, and M&A in 2016: Challenges and Conundrums for the West Coast
-
January 29, 2016
-
January 23, 2015
Antitrust, Governance, M&A in 2015: Challenges and Conundrums for the West Coast
-
November 14, 2013
The New Brazilian Takeover Panel and Listed Company M&A in Brazil